The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Lessons learned from the MitraSwiss registry

EuroIntervention 2020;16:e97-e99. DOI: 10.4244/EIJV16I2A14

1. Department of Cardiology, Vivantes Klinikum im Friedrichshain und Am Urban, Berlin, and Rostock University Medical Center, Rostock, Germany

n this issue of EuroIntervention, Sürder et al report the outcomes of percutaneous mitral valve repair (PMVR) by means of the MitraClip® (Abbott Vascular, Santa Clara, CA, USA) within the Swiss national registry1.

Outcomes were compared according to mitral regurgitation (MR) aetiology – 652 (53.8%) primary (degenerative) versus 560 (46.2%) secondary (functional) MR patients. Acute procedural success was similar in the two groups (>90%). Although the five-year cumulative probabilities of death and major adverse clinical events (MACE) were significantly higher in secondary MR, only age, haemoglobin level, creatinine level, and left ventricular ejection fraction (LVEF%) were independent predictors of ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
TAV-in-TAV for failed prosthesis: the new frontier

Latest news